116

DAFTAR PUSTAKA

1. World Health Organization: The Millenium Development Goals

Report 2005. Diunduh dari: http//milleniumindicators.un.org/unsd
/mi/pdf/MDG %20Book.pdf. Tanggal akses 28 September 2013.
2. Reed L, Carroll J, Cummings A, Markwell S, Wall J, Duong M. Serum
lactate as a screening tool dan predictor of outcome in pediatric
patients presenting to the emergency department with suspected
infection. Pediatric Emergency Care 2013;29:787-91.
3. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM,
dkk.

Surviving

sepsis

campaign:

International

guidelines

for

management of sever sepsis and septic shock: 2012. Crit Care Med
2013;41:580-637.
4. Hendra, Runtunuwu AL, Manoppo JIC. Pediatric logistic organ
dysfunction (PELOD) score as prognosis of multiple organ failure in
sepsis. Paediatr Indones 2010;50:226-32.
5. Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis.
Pediatr Crit Care 2005;6:S3-S5.
6. Hartman ME, Linde-Zwible WT, Angus DC, Watson RS. Trends in the
epidemiolgy

of

pedeiatric

severe

sepsis.

Pediatr

Crit

Care

2013;14:686-93.
7. Han YY, Carcillo JA, Dragotta MA. Early reversal of pediatricneonatal septic shock by community physicians is associated with
improved outcome. Pediatrics 2003;112:793-9.
8. Jat KR, Jhamb U, Gupta VK. Serum lactate levels as the predictor of
outcome in pediatric septic shock. Indian Journal of Critical Care Med
2011;15:102-7.
9. Duke TD, Butt W, South M. Predictors of mortality and multiple organ
failure in children with sepsis. Intensive Care Med 1997;23:684-92.
10. Hatherill M, Tibby SM, Evans R, Murdoch IA. Gastric tonometry in
septic shock. Arch Dis Child 1998;78:155-8.
11. Kim YA, Ha EJ, Jhang WK, Park SJ. Early blood lactate area as a
prognostic marker in pediatric septic shock. Intensive Care Med
2013;14:1-6.

117

12. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler
JA, dkk. Early lactate clearance is associated with improved outcome
in severe sepsis and septic shock. Crit Care Med 2004;32:1637-42.
13. Walker CA, Griffith DM, Gray AJ, Datta D, Hay AW. Early lactate
clearance in septic patient with elevated lactate levels admitted from
the emergency department to intensive care unit: Time to aim
higher? Journal of Critical Care 2013;28:832-7.
14. Marty P, Roquilly A, Valee F, Luzi A, Ferre F, Fourcade O, dkk.
Lactate clearance for death prediction in severe sepsis or septic
shock patients during the first 24 hours in intensive care unit:
obsservational study. Annal of Intensive Care 2013;3:1-7.
15. Performance of the pediatric index of mortality-2 (PIM-2) in cardiac
and mixed intensive care unit in tertiary childrens referral hospital in
Italy.BMC pediatrics 2013;13:1-8.
16. Salamati P, Talaee S, Eghbalkhah A, Chaman R, Mokthtari Z,
Azarshahin M. Validation of pediatric of mortality-2 scoring system in
a single pediatric intensive care unit in Iran. Iran J Pediatr
2012;22:481-6.
17. Morris KP, McShane P, Stickley J, Parslow RC. The relationship
between blood lactate concentration, the paediatric index of
mortality-2 (PIM-2) and mortality in paediatric intensive care.
Intensive Care Med 2012;38:2042-6.
18. Dellinger RP, Carlet JM, Masur H, Opal SM, Gerlach H, Annane D,
dkk. Campaign guidelines for management of severe sepsis and
septic shock. Crit Care Med 2004;32:858-73.
19. Dewi R. Sepsis pada anak: pola kuman dan uji kepekaan. Maj
Kedokt Ind 2011;61:101-6.
20. Kumar A, Zarcyhanski R, Light B. Early combination antibiotic
therapy yields improved survival compared with monotherapy in
septic shock: a prospensity-matched analysis. Crit Care Med
2010;38:1773-85.
21. Watson RS. The epidemiology of severe sepsis in children in the
United States. Am J Respir Crit Care Med 2003;167:695-701.

118

22. The

wolrd

health

report

2000:

health

systems:

improving

performance. Geneva Switzerland, Wolrd Health Organization. 2000.

23. Bateman BT, Schmidt U, Berman MF, Bittner EA. Temporal trends in
the epidemiology of severe postoperative sepsis after elective
surgery. Anasthesiology 2010;112:917-25.
24. Pavare J, Grope I, Gardovska D. Prevalence of systematic
inflammatory response syndrome (SIRS) in hospitalized children: a
pilot prevalence study. BMC Pediatr. 2009 Apr 3.
25. Abbas AK, Lichtman. Cellular and molecular immunology. Edisi ke-5
Philadelphia: Elsevier Saunders, 2005.
26. Roitt IM. Essential immunology; edisi ke-6. Oxford: Blackwell
Scientific 2005;164-77.
27. Kawai T, Akira S. The role of pattern-recognition receptors and
inflammation. Cell 2010;140:805-20.
28. Bateman SL, Seed PC. Procession to pediatric bacteremia and
sepsis: Covert operations and failures in diplomacy. Pediatrics
2010;126:137-50.
29. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial
infection. J Immunol 2008;181:3733-9.
30. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S,
Remick DG. The pathogenesis of sepsis. Annu Rev Pathol
2011;6:19-48.
31. Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet infect
Dis 2008;8:32-43.
32. Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol
2008;214:211-23.
33. Maa MC, Leu TH. Activation of Toll like receptors induces
macrophage migration via the iNOS/Src/FAK pathway. Biomedicine
2011;1:11-5.
34. Harmon PA. Pediatric Sepsis: The infection unto Death. Crit Care
Nurs Clin Am 2005;17:417-29.
35. Atkinson TJ. Toll-like receptors, Transduction-Effector Pathways, and
Disease Diversity: Evidence of an Immunological Paradigma
Explaining All Human Illness?. Int Rev Immunol 2008;27:255-81.

119

36. Ying-gang Z, Jie-ming Q. Toll like receptors and inflammatory factors

in sepsis and differential expression related to age. Chin Med J
2007;120:56-61.
37. Cena J, Chow AK, Schulz R. Nitric oxide, peroxynitrite and matrix
metalloproteinases: Insight into the pathogenesis of sepsis. Advance
in Experimental Biology 2007;01:367-95.
38. Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE. Innate
Immune Reponses to Danger Signals in Systemic Inflammatory
Response Syndrome and Sepsis. Scand J Immunol 2009;69:479-91.
39. Billack B. Macrophage activation: Role of Toll-like Receptors , Nitric
Oxide,

and

Nuclear

Factor

kappa

B. Amercan

Journal

of

Pharmaceutical Education. Am J Pharm Educ 2006;70:1-10.

40. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a
primer. Crit Care Med 2009;37:291-304.
41. Kennedy AD, DeLeo FR. Neutrophil apoptosis and the resolution of
infection. Immunol Res 2009;43:25-61.
42. Alcaide P, Aurebach S, Luscinskas FW. Neutrophil recruitment under
shear flow: Its all about endothelial cell rings and gaps.
Microcirculation 2009;16:43-57.
43. Urban CF, Lourido S, Zychlinsky A. How do microbes evade
neutrophil killing? Cell Microbiol 2006;8:1687-96.
44. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis.
N Engl J Med 2003;348:138-50.
45. Murphey ED, Lin CY, McGuire RW, Toliver-Kinsky T, Herndon DN,
Sherwood ER. Diminished bacterial clearance is associated with
decreased IL-12 and interferon- production but a sustained
proinflammantory response in a murine model of postseptic
immunosupression. Shock 2004;21:415-25.
46. Huang HW, Tang JL, Han XH, Peng YP, Qiu YH. Lymphocyte-derived
catecholamines induce a shift of Th1/Th2 balance toward Th2
polarization. Neuroimmunomodulation 2013;20:1-8.
47. Kasten KR, Tschop J, Adediran SG, Hildeman DA, Caldwell CC. T
cells are potent early mediators of the host response to sepsis.
Shock 2010;34:327-36.

120

48. Luan YY, Dong N, Xie M, Xiao XZ, Yao YM. The significance and
regulatory mechanisms of innate immune cells in the development of
sepsis. Journal of Interferon & Cytokine Research 2013;10:1-14.
49. Roger PM, Hyvernat H, Breittmayer JP, Dunais B, Dellamonica J.
Enhanced T-cell apoptosis in human septic shock is associated with
alteration of the costimulatory pathway. Eur J Clin Microbiol Infec Dis
2009;28:575-84.
50. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisted.
Annu Rev Immunol 2005;23:515-48.
51. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A.
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal
antibody TGN 1412. N Engl J Med 2006;355:1018-28.
52. Nolan A, Weiden M, Kelly A, Hoshino Y, Hoshino S. CD40 and
CD80/86 act synergistically to regulate inflammation and mortality in
polymicrobial sepsis. Am J Respir Crit Care Med 2008;177:301-8.
53. Nolan A, Kobayashi H, Naveed B, Kelly A, Hoshino Y. Differential role
for CD80 and CD86 in the regulation of the innate immune response
in murine polymicrobial sepsis. PloS One 2009;4:e6600.
54. Gold JA,Parsey M, Hoshino Y, Hoshino S, Nolan A. CD40 contributes
to lethality in acute sepsis: in vivo role for CD40 in innate immunity.
Infect Immun 2003;71:3521-8.
55. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N
Engl J Med 2009;361:1570-83.
56. Bayir H, Kagan VE. Bench-to-bedside review: Mitochondrial injury,
oxidative stress and apoptosis-there is nothing more practical than a
good theory. Crit Care 2008;12:206-9.
57. Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte
apoptosis and its significance in sepsis and shock. J Leukoc Biol
2005;78:325-37.
58. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: A
primer. Crit Care Med 2009;37:291-304.
59. Hotchkiss RS, Nicholson DW. Apoptosis and caspase regulate death
and inflammation in sepsis. Nat Rev Immunol 2006;6:813-22.

121

60. Berghe TV, Kalai M, Denecker GA, Saelens MX, Vandenabeele P.

Necrosis is associated with IL-6 production but apoptosis is not. Cell
Signal 2006;18:328-35.
61. Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond.
Cell Death Differ 2003;10:26-35.
62. Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial of reactive
oxygen species. Biochemistry 2005;70:200-14.
63. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CI, Lesnefsky EJ.
Production of reactive oxygen species by mitochondria central role of
complex III. J Biol Chem 2003;278:36027-31.
64. Festjens N, Berghe TV, Vandenabeele P. Necrosis, a wellorchestrated form of cell demise: signalling cascades, important
mediators and concomintant immune response. Biochemica et
Biophysica Acta 2006;1757:1371-87.
65. Festjens N, Kalai M, Smet J, A Meeus, R Van Coster, X Saelens, dkk.
Butylated hydroxyanisole is more than a reactive oxygen species
scavenger. Cell Death Differ 2006;12:166-9.
66. Carre JE, Singer M. Cellular energitic metabolism in sepsis: The
need for a system approach. Biochimica et Biophysica Acta
2008;1777:763-71.
67. Ellger B, Debayeve Y, Van Der Berghe G. Endocrine interventions in
the ICU. Eur J Inter Med 2005;16:71-82.
68. Fredriksson K, Hammarqvist F, Strigard K, Ljungqvist O, Wernerman
J, Rooyackers O, dkk. Derangements in mitochondrial metabolism in
intercostal and leg muscle of critically of critically ill patient with
sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab
2006;291:1044-50.
69. Brealey D, Brand M, Hagreaves I, Heales S, Smolenski R, Davies
NA. Association between mitochondrial dysfunction and severity and
outcome of septic shock. Lancet 2002;360:219-23.
70. Boutilier RG. Mechanisms of cell survival in

hypoxia

and

hypothermia. J Exp Biol 2001;204:3171-81.

71. Jekasbone A, Neher JJ, Borutaite V, Brown GC. Nitric oxide from
neuronal nitric oxide synthase sensities neurons to hypoxia-induced

122

death

via

competititve

inhibition

of

cytochrome

oxidase.

Neurochem 2007;103:346-56.
72. Dyson A, Stidwill R, Taylor V, Singer M. Tissue oxygen monitoring in
rodent models of shock. Am J Physiol Heart Circ 2007;7:200-3.
73. Crouser ED. Mitochondrial fysfunction in septic shock and multiple
organ dysfunction syndrome. Mitochodnrion2004;4:729-41.
74. Guo X, Li H, Xu H, Woo S, Dong H, Lu F, dkk. Glycolysis in the
control of blood glucose homeostasis. Acta Pharmaceutica Sinica B
2012;4:358-67.
75. Levin BE. Metabolic sensing neurons and the control of energy
homeostasis. Physiol Behav 2006;89:486-9.
76. Pomerantz WJ, Weiss SL, Torrey SB, Kaplan SL, Randolph AG,
Wiley II JF. Systemic inflammatory response syndrome (SIRS) and
sepsis in children: Definitions, epidemiology, clinical manifestations
and diagnosis. Diunduh dari http://www.uptodate.com/contents.
Tanggal akses 1 Oktober 2013.
77. Gaines NN, Patel B, Williams MD, Cruz AT. Etiologies of septic shock
in a pediatric emergency department population. Pediatr Infect Dis J
2012;31:1203-8.
78. Goldstein B, Giroir B, Randolph A, members of International
Consensus Conference on Pediatric Sepsis. International pediatrics
sepsis concencus conference: Definitions for sepsis and organ
dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8.
79. Brierley J, Carcillo JA, Choong K, Cornell T, DeCaen A, Deymann A,
dkk. Clinical practice parameters for hemodynamic support of
pediatric and neonatal septic shock: 2007 update from the American
College of Critical Care Medicine. Crit Care Med 2009;37:666-88.
80. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, dkk.
International

sepsis

definitions

conference.

Crit

Care

Med

2003;31:1250-6.
81. Simon L, Saint-Louis P, Amre DK, Lacroix J, Gauvin F. Procalcitonin
and C-reactive protein as markers of bacterial infection in critical ill
children at onset of systematic inflammatory response syndrome.
Pediatr Crit Care Med 2008;9:407-13.

123

82. Povoa P, Almeida E, Moreira P, Fernandes A, Mealha N, Aragao A,

dkk. C-reactive protein as an indicator of sepsis. Intensive Cre Med
1998;24:1052-6.
83. Kota SK, Meher LK, Rao ES, Jammula S, Modi KD. Utility of
biomarker in sepsis: Mirror reflection of inner trunculent devil.
Bangladesh Journal of Medical Science 2013;12:17-29.
84. Fioretto JR, Martin JG, Kurokawa CS, Carpi MF, Bonatto RC, Moraes
MA, dkk. Comparasion between procalcitonin and C-reactive protein
for early diagnosis with sepsis or septic shock. Inflamm Res
2010;59:581-6.
85. Gladden LB. Lactate metabolism: a new paradigm for the third
millenium. J Physiol 2004:558:5-30.
86. Phypers B, Pierce JMT. Lactate physiology in health and disease.
Critical Care & Pain 2006;6:128-32.
87. Gladden LB. Lactate metabolism: a new paradigm for the third
millenium. J Physiol 2004;558:5-30.
88. Jansen TC, Van Bommel J, Woodward R, Mulder PGH, Bakker J.
Association between blood lactate levels, sequential organ failure
assessment subscores, and 28-day mortality during early and late
intensive care unit stay: a restrospective observational study. Crit
Care Med 2009;37:2369-74.
89. Boldt J, Kumle B, Suttner S, Haisch G. Point-of-care (POC) testing of
lactate in the intensive care patient. Acuuracy, reability, and cost of
differrent

measurement

system.

Acta

Anaesthesiol

Scand

2001;45:194-9.
90. Lavery RF, Livingston DH, Tortella BJ, Sambol JT, Slamovitz BM,
Siegel JH. The utility of venous lactate to triage injured patient in the
trauma center. J Am Coll Surg 2000;190:656-64.
91. Gallagher EJ, Rodriguez K, Touger M. Agreement between
peripheral venous and arterial lactate levels. Acad Emerg Med
1996;29:479-83.
92. Assuncao M, Naslente A, Guedes L, Mazza B, Jacki M, Fernande H,
dkk. Lactate levels from arterial, central venous and peripheral

124

venous blood in severe septic and septic shock patients. Critical

Care 2007;11:P452-7.
93. Kruse O, Grunnet N, Barford C. Blood lactate as a predictor for inhospital mortality in patients admitted acutely to hospital: a
systematic

review.

Resuscitation

and

Emergency

Medicine

2011;19:1-12.
94. Songa PM, Castelnuovo B, Mugasha EB, Ocama P, Kambugu A.
Symptomatic hyperlactatemia associated with nucleoside analogue
reverse-transcriptase inhibitor use in HIV-infected patients:a report of
24 cases in a resource-limited setting (Uganda). CID 2007;45:514-7.
95. Waiswa M, Byarugaba BB, Ocama P, Mayanja-Kizza H, Seremba E,
Ganguli S, dkk. Hyperlactatemia and concurrent use of antiretroviral
therapy among HIV infected patients in Uganda. African Health
Science 2012;12:268-75.
96. Perez EH, Dawood H, Chetty U, Estherhuizen TM, Bizaare M.
Validation of the accutrend lactate meter for hyperlactatemia
screening during antiretroviral therapy in a resource-poor setting. Int
J of Infectious diseasae 2008;12:553-6.
97. Jansen TC, Bommel JV, Mulder PG, Rommes JH, Schieveld SJM,
Bakker J. The prognostic value of blood lactate levels relative to taht
of vital signs in the pre-hospital setting:a pilot study. Critical Care
2008;12:1-7.
98. Moore CC, Jacob ST, Pinkerton R, Meya DB, Mayanja-Kizza H,
Reynolds SJ, dkk. Point-of-care lactate testing predicts mortality of
severe sepsis in predominantly HIV type 1-infected patient
population in Uganda. CID 2008;46:215-22.
99. Shann F, Pearson G, Slater A, Wilkinson K. Paediatric index of
mortality (PIM): a mortality model for children in intensive care.
Intensive Care Med 1997;23:201-7.
100. Slater A, Shann F, Pearson G. PIM2: a revised version of the
paediatric index of mortality. Intensive Care Med 2003;29:278-85.
101. Salamati P, Talaee S, Eghbalkhah A, Chaman R, Mokhtari Z,
Azarshahin M. Validation of pediatric index of mortality-2 scoring

125

system in a single pediatric intensive care unit in iran. Iran J Pediatr

2012;22:481-6.
102. Kvolik S, Peric

ID,

Takac

I,

Jukic

M,

Drenjancevic

D.

Microcirculation impairment and blood pressure in sepsis. Med Glas

2009;6:32-41.
103. National High Blood Pressure Education Program Working Group
on High Blood Pressure in Children an Adolescents. The fourth report
on the diagnosis, evaluation, and treatment of high blood pressure in
children and adolescent. Pediatrics 2004;114:555-76.
104. Setyabudhy, Mangunatmadja I, Yuliarto S. Evaluasi diagnosis dan
tata laksanan penurunan kesadaran pada anak. Dalam : Pudjiadi AH,
Latief A, Budiwardhana N, penyunting. Jakarta. IDAI. 2013.h.19-29.
105. Leteurtre S, Dupre M, Lampin ME. Assessment of the pediatric
index of mortality 2 (PIM2) score with the PaO2, FiO2 ratio derived
from the SPO2/FiO2 ratio. Chest 2009:135-8.
106. Ferguson LP, Durward A, Tibby SM. Relationship between arterial
partial oxygen pressure after resuscitation from cardiac arrest and
mortality in children crinical perspective.Circulation 2012;126:335-42.
107. Stack AM. Cyanosis. Dalam : Fleisher GR, Ludwig S, penyunting.
Textbook of pediatric emergency medicine. Edisi 6. Philadelphia.
Lippincott Williams & Wilkins. 2010.h.198-202.
108. Latief A, Setiati TE, Kushartono H. Keseimbangan asam basa.
Dalam : Pudjiadi AH, Latief A, Budiwardhana N, penyunting. Jakarta.
IDAI. 2013.h.141-52.
109. Bell LM. Shock. Dalam : Fleisher GR, Ludwig S, penyunting.
Textbook of pediatric emergency medicine. Edisi 6. Philadelphia.
Lippincott Williams & Wilkins. 2010.h.46-57.
110. Assessment and optimazation of mortality prediction tools for
admissions to pediatric intensive care in the UK. Pediatrics.
2006:733-42.
111. Marr J, Abramo TJ. Monitoring in critically ill children. Dalam: Baren
JM. Pediatric emergency medicine. Philadelphia. Saunders Elsevier.
2008. h.50-7.
112. Leteurtre S, Martinot A, Duhanel A, Grandbastein B, Cotting J,
Gotresman R, dkk. Validation of pediatric logistic organ dysfunction

126

(PELOD) score: prospective, observational, multicentre study. Lancet

2003;362:192-7.
113. Pollack MM, Ruttiman UE, Getson PR. Pediatric risk of mortality
(PRISM) score. Crit care Med.1988;1110-6.
114. Costa GDA, Delgado AF, Ferraro A, Okay TS. Application of the
pediatric rsik of mortality score (PRISM) score and determination of
mortality risk factors in a tertiary pediatric intensive care unit. Clinics
2010;11:1087-92.
115. Bellad R, Rao S, Patil VD, Mahantshetti NS. Outcome of intensive
care unit patients using pediatric risk of mortality (PRISM) score.
Indian Pediatr 2009;46:1091-2.
116. Hatherril M, MeIntyre AG,

Wattie

M,

Murdoch AL.

Early

hyperlactatnemia in critically ill children. Intensive Care Med

2000;26:314-8.
117. Nguyen HB, Loomba M, Yang JJ, Jacobsen G, Shah K, Otero RM,
dkk. Early lactate clearance is associated with biomarkers of
inflammation, coagulation, apoptosis, organ dysfunction and mortality
in severe sepsis and septic shock. Journal of Inflammation 2010;7:111.
118. Puskarich MA, Trzeciak S, Shapiro NI, Albers AB, Heffner AC, Kline
JA, dkk. Whole blood lactate kinetics in patients undergoing
quantitative resuscitation for severe sepsis and septic shock. Chest
2013;143:1548-53.
119. Sjarif DR, Nasar SS, Devaera Y, Tanjung CF, penyunting. Asuhan
nutrisi pediatrik. Jakarta:UKK Nutrisi dan Penyakit Metabolik;2011.